Antibodies attacking virus (illustration)

Image source: Shutterstock/Christoph Burgstedt

News • Immune response determined

How Covid-19 vaccines prepare our immune system for the virus

In view of the continuing high numbers of infections, vaccination offers important protection against severe Covid-19 disease.

Scientists from the Faculty of Medicine – University of Freiburg have now been able to determine in detail at what time point initial immune protection is established after vaccination with an mRNA-based vaccine and how the reactions of the various components of the human immune system develop over months. The researchers published their results in the online edition of the journal Nature

"Already ten days after prime vaccination, there is effective protection against severe disease. At this point, however, neutralizing antibodies preventing the virus from entering cells are barely detectable. Instead, this early protective effect is due to specific T cells controlling the cellular immune response," says Dr. Maike Hofmann, Head of a research group at the Department of Internal Medicine II at Medical Center – University of Freiburg.

Recommended article

Photo

News • Covid-19 detection

New blood test measures immunity against SARS-CoV-2 and its variants

The Lausanne University Hospital (CHUV) and EPFL teamed up to develop a new test that’s sensitive enough to measure the amount of SARS-CoV-2 neutralizing antibodies present in the bloodstream. The scientists’ discovery, published in Science Translational Medicine, opens promising new avenues for tracking immunity acquired by infection or vaccination.

The scientists examined blood samples from 32 volunteers before prime vaccination and at intervals of three to four days continuously for up to four months after boost vaccination. This allowed them to follow the development of the different components of the immune response in detail. "In the majority of subjects, a relevant increase in so-called CD8+ T cells precisely tailored to the SARS-CoV-2 spike protein could be detected as early as six to eight days after prime vaccination," reports Prof. Dr. Christoph Neumann-Haefelin, Head of the Gerok Liver Center at Medical Center – University of Freiburg.

Our results underscore the importance of complete vaccination with two doses of the mRNA vaccine for adequate protection against infection

Christoph Neumann-Haefelin

After boost vaccination, the number of CD8+ T cells increased. Only at this point neutralizing antibodies could be detected in quantities large enough to prevent the virus from invading cells and thus the infection itself. "Our results underscore the importance of complete vaccination with two doses of the mRNA vaccine for adequate protection against infection," Neumann-Haefelin adds.

Perspectives for other vaccines

The potent combination of a rapid T-cell response and neutralizing antibodies is evidence of the high efficacy of the still-new mRNA vaccination technology. Follow-up studies will have to show how long protection lasts after boost vaccination and when a second boost vaccination - possibly adapted to new virus variants - will be necessary. "The more precisely we understand how the mRNA vaccination works, the sooner we will be able to develop it further for other diseases - for example, for a future vaccination against hepatitis C or a therapeutic vaccination against cancer," explains Prof. Dr. Robert Thimme, Medical Director of the Department of Internal Medicine II at Medical Center – University of Freiburg. "The fact that important insights into the development of a solid immune response to SARS-CoV-2 could be gained and published within a few months is proof of the great expertise and commitment of our researchers," says Prof. Dr. Lutz Hein, Dean of the Faculty of Medicine – University of Freiburg. 


Source:  University of Freiburg – Medical Center 

29.07.2021

Read all latest stories

Related articles

Photo

News • Protein malformation

Covid-19: immune reaction may cause amyloid generation

In patients with serious and long-term Covid-19, disturbed blood coagulation is often observed. Now, Swedish researchers found a connection between harmful amyloid production and Covid-19 symptoms.

Photo

News • Effective prevention

Covid-19 vaccination greatly reduces infectious viral load

By comparing the infectious viral load caused by ancestral SARS-CoV-2 as well as by the Delta and Omicron variants, scientists highlight the benefits of vaccination.

Photo

News • Covid-19 drug monitoring

Smart sensor to evaluate vaccine safety

A new study enables developers to determine vaccine safety via smart sensors that measure objective physiological parameters. This could end the reliance on subjective reports of study participants.

Related products

Beckman Coulter – Access Procalcitonin (PCT)

Immunoassays

Beckman Coulter – Access Procalcitonin (PCT)

Beckman Coulter Diagnostics
Beckman Coulter – SARS-CoV-2 Assays

Immunoassays

Beckman Coulter – SARS-CoV-2 Assays

Beckman Coulter Diagnostics
Fujifilm Wako – μTASWako i30

Immunoassays

Fujifilm Wako – μTASWako i30

FUJIFILM Wako Chemicals Europe GmbH
Lifotronic  SARS-CoV-2 Antibody Detection Kit

Immunoassays

Lifotronic SARS-CoV-2 Antibody Detection Kit

Lifotronic Technology Co., Ltd
Subscribe to Newsletter